Drug Type Gene therapy |
Synonyms- |
Target |
Mechanism TCF4 modulators(transcription factor 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Mahzi Therapeutics, Inc.Startup |
Active Organization Mahzi Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pitt-Hopkins Syndrome | Preclinical | US | Mahzi Therapeutics, Inc.Startup | 01 Sep 2024 |